Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Salmon Sean, Vice-Président Exécutif et Président, Diabète/Cardiovasculaire. Director active across 2 companies, notably Medtronic plc. Cumulatively, 16 filings have been recorded. Activity tracked since 2 August 2021. The latest transaction was disclosed on 8 September 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Salmon Sean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,272 shares@ US$131.3119.7% of flowOrdinary SharesSEC:0001127602-21-023105:0
16 of 16 declarations
About Salmon Sean
Salmon Sean is Executive Vice President and President, Diabetes/Cardiovascular. He has 15 filings in total, all with Medtronic plc, and the sampled recent filings cover the period from 2021-08-04 to 2024-12-17. In these recent filings, the most common transaction nature is tax withholding, and the largest amounts are 696440.0513497626 EUR, 251237.9750070307 EUR, and 94878.61120396896 EUR.